ArticleCase reports in obstetrics and gynecology2026
A Rare Case of Uterine Artery Pseudoaneurysm After Hysteroscopic Management of Trophoblastic Disease.
Article in Case reports in obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Rare Case of Uterine Artery Pseudoaneurysm After Hysteroscopic Management of Trophoblastic Disease.Case reports in obstetrics and gynecology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Uterine artery pseudoaneurysm (UAP) is a rare but potentially life-threatening condition, most commonly associated with childbirth and less frequently with intrauterine procedures such as dilatation and curettage or hysteroscopy. Its incidence is estimated at 3-6 per 1000 deliveries, whereas occurrence in the context of gestational trophoblastic disease (GTD) is extremely uncommon. UAP may remain asymptomatic before presenting as sudden vaginal hemorrhage days to weeks after uterine intervention. Prompt recognition and timely imaging are essential for effective management. Computed tomography (CT) angiography is considered the gold standard, whereas Doppler ultrasound and magnetic resonance imaging (MRI) are valuable alternatives. Uterine artery embolization is the preferred treatment due to its high success rate and fertility-preserving potential. Case Presentation: We report an exceptionally rare case of UAP developing 5 weeks after hysteroscopic removal of retained products of conception in the context of GTD. Power Doppler ultrasonography demonstrated a hypervascular lesion with a characteristic swirling flow pattern, confirmed by contrast-enhanced CT. The patient underwent successful selective uterine artery embolization, resulting in complete symptom resolution. Over 5 years of follow-up, she remained recurrence-free, with regular menstruation and a subsequent full-term delivery, indicating preserved reproductive function. Discussion: This case highlights the importance of considering UAP in delayed posthysteroscopic hemorrhage, particularly in GTD. Multimodal imaging is essential for accurate diagnosis and differentiation from other vascular lesions. Selective uterine artery embolization is a safe, effective, and fertility-preserving treatment with favorable long-term outcomes, including successful pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.